Literature DB >> 15483471

Association of complementary and alternative medicines with HIV clinical disease among a cohort of women living with HIV/AIDS.

Isis S Mikhail1, Ralph DiClemente, Sharina Person, Susan Davies, Elizabeth Elliott, Gina Wingood, Pauline E Jolly.   

Abstract

To assess the association between the use of complementary and alternative medicine (CAM) and HIV clinical disease indicators, CD4+ T-cell counts, viral load, number of HIV-related infections, Centers for Disease Control and Prevention categories, and Karnofsky scores. Data were collected from 391 HIV-positive women aged 18 to 50 years in Alabama and Georgia. A survey examining CAM use and other sociodemographic variables was used. Multiple logistic regression analyses were used to identify predictors of CAM use. Approximately 60% of study participants used 1 or more type of CAM. Predictors of CAM use included higher educational level (odds ratio [OR] = 2.4; P = 0.0008), absence of health insurance (OR = 0.49; P = 0.0055), longer disease duration (OR = 2.21; P = 0.0006), and higher number of infections (OR = 0.58; P = 0.017). Vitamins were the most commonly used CAM ( approximately 36%). Sociodemographic variables associated with vitamin use included higher educational level (OR = 2.34; P = 0.0055), longer disease duration (OR = 1.87; P = 0.026), and higher use among white women than among African-American women (OR = 0.41; P = 0.017). The use of CAM is prevalent among HIV-positive women, and vitamins are the most commonly used CAM among our study population. Several sociodemographic and clinical factors predicted CAM use. These findings have implications for improvement of care for HIV-positive women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483471     DOI: 10.1097/01.qai.0000130549.65946.3d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  10 in total

1.  Development and evaluation of a complementary and alternative medicine use survey in African-Americans with acquired immune deficiency syndrome.

Authors:  Ashli Owen-Smith; Claire Sterk; Frances McCarty; Dana Hankerson-Dyson; Ralph Diclemente
Journal:  J Altern Complement Med       Date:  2010-05       Impact factor: 2.579

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

Review 3.  Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  AIDS Care       Date:  2008-09

Review 4.  The assessment of complementary and alternative medicine use among individuals with HIV: a systematic review and recommendations for future research.

Authors:  Ashli Owen-Smith; Lara DePadilla; Ralph DiClemente
Journal:  J Altern Complement Med       Date:  2011-09       Impact factor: 2.579

5.  Knowledge, beliefs, and health care practices relating to treatment of HIV in Vellore, India.

Authors:  Anne Marie Belz Chomat; Ira B Wilson; Christine A Wanke; A Selvakumar; K R John; Rita Isaac
Journal:  AIDS Patient Care STDS       Date:  2009-06       Impact factor: 5.078

6.  Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection.

Authors:  Felise B Milan; Julia H Arnsten; Robert S Klein; Ellie E Schoenbaum; Galina Moskaleva; Donna Buono; Mayris P Webber
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

7.  Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome.

Authors:  Ashli Owen-Smith; Frances McCarty; Dana Hankerson-Dyson; Ralph Diclemente
Journal:  Focus Altern Complement Ther       Date:  2012-02-16

Review 8.  Successful aging and the epidemiology of HIV.

Authors:  David E Vance; Teena McGuinness; Karen Musgrove; Nancy Ann Orel; Pariya L Fazeli
Journal:  Clin Interv Aging       Date:  2011-06-28       Impact factor: 4.458

9.  MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro.

Authors:  Mamdooh Ghoneum; Magda Shaheen
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

10.  Gene Expression Profiles of HIV/AIDS Patients with Qi-Yin Deficiency and Dampness-Heat Retention.

Authors:  Sa Liu; Yulong Chen; Shiping Xie; Qianlei Xu; Jianshe Chen; Changhai Wang; Zhao Wang; Suna Ma; Xingwei Wu; Ning Zhang
Journal:  J Altern Complement Med       Date:  2016-10-19       Impact factor: 2.579

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.